Related references
Note: Only part of the references are listed.Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization
Liyan Liu et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes:: a pooled analysis within the InterLymph consortium
Karin Ekstrom Smedby et al.
BLOOD (2008)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration
SL Brown et al.
ARTHRITIS AND RHEUMATISM (2002)
Inflammatory bowel disease is not associated with an increased risk of lymphoma
JD Lewis et al.
GASTROENTEROLOGY (2001)
Share Paper
